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Although it is recognized that the mechanical stresses associated with physical activity augment bone mineral density and
improve bone quality, our understanding of how exercise modulates bone homeostasis at the molecular level is lacking. In a
before and after trial involving 43 healthy adults, we measured the effect of six months of supervised exercise training on the
spontaneous and phytohemagglutinin-induced production of osteoclastogenic cytokines (interleukin-1𝛼, tumor necrosis factor𝛼), antiosteoclastogenic cytokines (transforming growth factor-𝛽1 and interleukins 4 and 10), pleiotropic cytokines with variable
effects on osteoclastogenesis (interferon-𝛾, interleukin-6), and T cell growth and differentiation factors (interleukins 2 and
12) by peripheral blood mononuclear cells. We also measured lymphocyte phenotypes and serum markers of bone formation
(osteocalcin), bone resorption (C-terminal telopeptides of Type I collagen), and bone homeostasis (25 (OH) vitamin D, estradiol,
testosterone, parathyroid hormone, and insulin-like growth factor 1). A combination of aerobic, resistance, and flexibility exercises
done on average of 2.5 hours a week attenuated the production of osteoclastogenic cytokines and enhanced the production of
antiosteoclastogenic cytokines. These changes were accompanied by a 16% reduction in collagen degradation products and a
9.8% increase in osteocalcin levels. We conclude that long-term moderate intensity exercise exerts a favorable effect on bone
resorption by changing the balance between blood mononuclear cells producing osteoclastogenic cytokines and those producing
antiosteoclastogenic cytokines. This trial is registered with Clinical Trials.gov Identifier: NCT02765945.

1. Introduction
Interest in cytokines as regulators of bone metabolism began
with the experiments of Horton and associates who, in
1972, found that conditioned medium from PHA-stimulated
peripheral blood mononuclear cells contained bone resorbing activity [1]. This activity was eventually found to be due
to interleukin- (IL-) 1 and tumor necrosis factor- (TNF-) 𝛼
[2, 3], prompting a series of studies examining the role of
these and other proinflammatory cytokines as mediators of
bone resorption in periodontal disease, rheumatoid arthritis,
osteolytic malignancies, and osteoporosis [4–8]. In addition
to IL-1 and TNF-𝛼, the spectrum of cytokines with effects
on bone metabolism now includes the antiosteoclastogenic

cytokines IL-4 and IL-10 and transforming growth factor(TGF-) 𝛽, and two pleiotropic cytokines, interferon- (IFN-)
𝜆 and IL-6, whose effects on bone vary depending on
experimental conditions [9, 10].
Along with fall prevention and calcium and vitamin D
supplementation, the Surgeon General has recommended
regular physical activity as the first line in fracture prevention
in persons with low bone density [11]. Evidence indicates
that the mechanical stresses associated with physical activity
augment bone mineral density and improve bone quality by
promoting adaptive changes in its geometry and architecture
[12]. In the microgravity of space, however, bone loss continues at an average rate of one to two percent per month
despite the institution of vigorous exercise programs designed
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Description of study and request for
volunteers aged 30–60 placed in 3
newspapers
All 77 respondents assessed for
eligibility∗ (questionnaire, BMI, EKG, and
stress testing)
25 excluded
(i) Abnormal stress test (n = 5)
(ii) Not meeting other eligibility
criteria (n = 20)
52 enrolled in hospital based wellness center for
6 months of supervised exercise training+
Blood drawn for preexercise analysis
9 excluded
(i) Incomplete attendance (n = 8)
(ii) Moved (n = 1)
43 subjects (25 women, 18 men) with complete
training. Blood drawn for postexercise analysis

Figure 1: Flow diagram. ∗ Eligibility criteria: normal EKG, stress test, and exercise tolerance; absence of chronic inflammatory disease,
malignancy, immunodeficiency, and immunosuppressive therapy. + Each training session consisted of a combination of aerobic (60%),
resistance (weightlifting) (30%), and flexibility (stretching) (10%) exercises.

to duplicate conditions on Earth [13, 14], indicating that there
remains much to be learned about the mechanism(s) whereby
physical exercise (and gravity) influences the ontogeny and
functioning of hematopoietic and bone cells involved in the
maintenance of bone health.
We have investigated the possibility that long-term moderate intensity exercise improves bone health by favorably
altering the production of cytokines with osteoclastogenic
and antiosteoclastogenic properties by peripheral blood
mononuclear cells.

2. Methods
2.1. Subjects. This before and after clinical study was
approved by the Institutional Review Board of East Tennessee
State University. Each subject read and signed the informed
consent in the presence of an investigator.
Subjects aged 30 to 60 were recruited from the general
population by placing an outline of the study and a request
for volunteers in three local newspapers. A total of 77
persons responded and all agreed to be screened for eligibility
(see Figure 1). Fifty-two volunteers met eligibility criteria and
were enrolled in a hospital-based wellness center where they
underwent 6 months of supervised training. Subjects were
required to exercise for a minimum of 30 minutes twice a
week. Each training session consisted of a combination of
aerobic (60%), resistance (weightlifting) (30%), and flexibility (stretching) (10%) exercises. Aerobic exercise choices
included walking, running, cycling, rowing, climbing, skiing,
and aerobics.

Forty-three subjects (25 women, average age 48 years
[range 30–58], and 18 men, average age 49 years [range 35–
59]) successfully completed the study; their risk factors for
osteoporosis are listed in Table 1. Nine subjects were excluded:
8 did not meet attendance requirements and 1 moved to
another location.
Supervisors kept detailed records documenting attendance, the duration and type of each exercise, weights,
changes in medications, changes in dietary or smoking habits,
and state of health. These data, along with risk factors for
osteoporosis, were analyzed for their potential effects on
outcome measurements (cytokine production, C-terminal
telopeptides of Type I collagen, osteocalcin levels, hormonal
levels, lymphocyte phenotypes, and mitogen responses) and
for group and within-group differences.
Immunologic studies were done at baseline and after
completion of 6 months of training. In order to minimize
seasonal influences on the results, 2-3 subjects were enrolled
each month over an eleven-month period. Subjects were
instructed not to exercise outside of the supervised exercise
program and for at least 24 hours prior to blood drawing. All
blood samples were drawn in the morning at approximately
the same time of day.
2.2. Serum Assays. Solid-phase enzyme-linked immunoassay kits were used to measure serum levels of osteocalcin
(BRI-Diagnostics Bioresearch, Dublin, Ireland), C-terminal
telopeptides of Type I collagen (CTXI) (Osteometer Biotech
A/S, Herlev, Denmark), and relevant hormones (25 (OH)
vitamin D, estradiol, testosterone, parathyroid hormone, and
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Table 1: Risk factors for osteoporosis∗ .
Women (𝑛 = 25)
49.7 (7.2)
15 (60%)
16 (64%)
4 (16%)
9 (36%)

were subsequently assayed for IL-1𝛼, IL-2, IL-4, IL-6, IL-10,
IL-12, TNF-𝛼, IFN-𝛾, and TGF-𝛽1 using solid-phase enzymelinked immunoassay kits (Quantikine, R & D Systems,
Inc., Minneapolis, MN, for IL-1𝛼 and TGF-𝛽1; Predicta,
Genzyme Corp., Cambridge, MA, for TNF-𝛼; Cytoscreen,
BioSource International, Inc., Camarillo, CA, for IFN-𝛾; and
Immunotech, Inc., Westbrook, ME, for IL-2, IL-4, IL-6, IL-10,
and IL-12).

Of the women, 68% were amenorrheic (44%, postmenopausal; 24%,
posthysterectomy and oophorectomy). Of the amenorrheic women, 71%
were taking estrogen replacement medication.
Eight percent of women had five risk factors, 12% had four risk factors, 24%
had three risk factors, 36% had two risk factors, 16% had one risk factor, and
4% had no risk factors for osteoporosis. Fifty percent of men had one risk
factor and 50% had two risk factors for osteoporosis. Twenty-four percent of
women and 28% of men were obese (BMI > 30 kg/m2 ). None of the subjects
were hyperthyroid or taking glucocorticoids.
a
Normal values: men, 15–60 pg/mL; premenopausal women, 15–400 pg/mL
(follicular phase, 15–120 pg/mL; ovulation, 200–400 pg/mL; luteal phase,
175–325 pg/mL); postmenopausal women, 0–40 pg/mL. b No regular physical
activity for ≥1 year. c Five or more alcoholic beverages/week. Enrollment 25
(OH) vitamin D levels were normal (≥20 ng/mL) in all subjects.

2.5. Mitogenic Assays. Mitogenic responses were measured
by adding methyl-3 H-thymidine (20 𝜇Ci/mL, 50 𝜇L) to culture samples removed 6 hours prior to supernatant harvesting. Labeled samples were incubated under 5% CO2 at 37∘ C
for an additional 6 hours, and the cells were collected on
glass fiber filter paper using a Mash II Cell Harvester. Samples
were air-dried, placed in vials containing Scinti-Verse II, and
assayed with a Beckman LS 9800 liquid scintillation counter.
Proliferative responses are expressed as net counts per minute
(Δcpm), calculated as cpm in PHA-stimulated cultures minus
cpm in unstimulated cultures.

Age, mean (SD), y
Estradiol deficiencya
Inactivityb
Smoking
Alcoholc

Men (𝑛 = 18)
48.1 (8.0)
4 (28%)
11 (61%)
1 (6%)
9 (50%)

∗

insulin-like growth factor 1) (American Laboratory Products
Company, Salem, New Hampshire).
2.3. Lymphocyte Phenotyping. Immunophenotyping of blood
lymphocytes was done as previously described [52] using
lysed whole blood and a FACScan flow cytometer (Becton Dickinson, San Jose, Calif.) and fluorescein- and
phycoerythrin-labeled murine monoclonal IgG antibodies to
measure levels of T lymphocytes (CD3+ ); T helper lymphocytes (CD4+ ); T cytotoxic lymphocytes (CD8+ ); T lymphocytes displaying MHC class II antigen (DR+ ), vascular adhesion molecule-4 (VLA-4) (CD49d+ ), lymphocyte functionassociated antigen-1 (LFA-1) (CD11a+ ), Fas antigen (CD95+ ),
or gamma-delta T cell receptors (TCR𝛾𝛿+ ); B lymphocytes
(CD3− CD19+ ); B1 lymphocytes (CD3− CD19+ CD5+ ) and natural killer cells (NK cells) (CD3− CD16+ CD56+ ).
2.4. Cytokine Production. Cytokine production was measured as previously described [52]. Peripheral blood mononuclear cell (PBMC) preparations containing 15–20% monocytes and 80–85% lymphocytes were isolated from venous
blood using Accu-Prep (Accurate Chemical & Scientific
Corp., Westbury, NY), washed three times at 10∘ C with
sterile phosphate buffered saline (pH 7.4, 0.1 M), and suspended at a concentration of 2 × 106 cells/𝜇L in RPMI-1640
containing 5% heat inactivated human AB serum (v/v), Lglutamine (2 mM), penicillin (50 U/mL), and gentamicin and
streptomycin (50 𝜇g/mL each). Preparations were incubated
under 5% CO2 at 37∘ C for 48 hours with and without
phytohemagglutinin (PHA) (5 𝜇g/mL), a lectin mitogen that
stimulates unprimed T cells to proliferate by cross-linking
their T cell receptors (this assay provides a more definitive
assessment of T cell function than assays using unstimulated
(PHA− ) cultures). Culture supernatants were rendered cellfree by centrifuging at 1,000 ×g for 10 minutes at 12∘ C and
stored in 1-2 mL aliquots at −80∘ C for later use. Supernatants

2.6. Statistical Analysis. Statistical analysis was done using
STATISTICA (Statsoft, Inc., Tulsa, OK). The two-sided ttest for dependent samples was used to determine the significance of differences between measurements. The Pearson
correlation test was used to quantify the relationship between
two variables and linear regression was used to determine
the predictability of Y from X. One-way analysis of variance
(ANOVA) was used to compare measurements of three or
more groups. Unless stated otherwise, results are expressed
as the mean ± (SEM).

3. Results
3.1. Cytokine Production by PBMCs. In this analysis, we have
identified IFN-𝛾 as an osteoclastogenic cytokine and IL6 as an antiosteoclastogenic cytokine. In our opinion, this
most accurately reflects their effects on bone formation and
resorption. The reader is referred to Table 2 for a summary of
the effects of these and the other studied cytokines on bone
homeostasis and immune cell function.
3.2. Osteoclastogenic Cytokines. Postexercise TNF-𝛼 levels
fell by 52% and 28% in cultures with and without added
PHA (𝑝 ≤ .0031). IL1-𝛼 levels fell by 13% in PHA+ cultures
(𝑝 = .0472) and by 3% in PHA− cultures (𝑝 > .05). IFN-𝛾
levels fell by 71% in PHA+ cultures (𝑝 < .0001) and by 44%
in PHA− cultures (𝑝 = .0065) (Figure 2).
Collectively, osteoclastogenic cytokine production fell by
59% in PHA+ cultures (𝑝 < .0001) and by 24% in PHA−
cultures (𝑝 > .05); in PHA+ cultures, the percent reduction
was proportionate to the average time subjects spent per
training session doing aerobic exercises (Figure 3).
3.3. Antiosteoclastogenic Cytokines. Postexercise TGF-𝛽1 levels increased by 37% and 43% in cultures with and without
added PHA (𝑝 < .0001). IL-10 levels increased by 9% in
PHA+ cultures (𝑝 > .05) and by 940% in PHA− cultures
(𝑝 = .0025). IL-4 levels increased by 94% in PHA+ cultures
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Table 2: Modulation of bone and immune cells by cytokines.
T cells, B cells,
and
macrophages

Rodents (in
vivo)

Cytokine

Osteoblast

Osteoclast

IL1-𝛼/𝛽

↑ RANKL

↑ resorption

[2–8, 15, 16]

TNF-𝛼

↑ RANKL

↓ apoptosis
↓ apoptosis
↑
RANKL-independent
osteoclastogenesis

↑ resorption
↓ formation

[2–8, 16–18]

↓ RANKL signaling
pathways

↓ collagen
synthesis

IFN-𝛾
IL-4

↓ RANKL
↑ OPG

Il-6

↑ RANKL
↑ precursors
↓ apoptosis

↓ RANKL
signaling pathways

Il-10

↑ OPG

↓ RANKL signaling
pathways

↓ RANKL,
↑ OB differentiation and
synthesis of
OPG and
osteoid
matrix

↓ osteoid
degrading
enzymes
↑ Wnt1

TGF-𝛽

Osteocyte

Bone (in vitro)

↑ bone loss
↓ osteopetrosis
↓ bone loss

↑ TNF-𝛼,
RANKL

↓ bone loss

↑ production
with loading

[19–26]

↑ Th2-type
↓ Th1-type
↓ TNF-𝛼,
IL-1𝛼/𝛽
↑ IL-4, IL-10,
IL-1ra, OPG,
and B cell
maturation
↓ IFN-𝛾,
IL-1𝛼/𝛽, TNF-𝛼,
and T helper cell
proliferation

↑ production
with loading

↓ TNF-𝛼,
IL-1𝛼/𝛽, and
IFN-𝛾

↑ osteoid matrix

References

[27–29]

[30–42]

[43–46]

[41, 47–51]

RANKL, receptor activator of nuclear factor kappa B ligand, promoting osteoclastogenesis by binding to RANK on osteoclast precursors. OPG, osteoprotegerin;
a decoy RANKL receptor & potent inhibitor of osteoclastogenesis. Wnt1, a protein crucial to normal bone formation. IL-1ra, interleukin-1 receptor antagonist.
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Figure 2: Effect of exercise on osteoclastogenic cytokine production. Exercise attenuated the production of TNF-𝛼 and IFN-𝛾 in both PHA−
and PHA+ cultures. IL1-𝛼 values also fell in PHA+ cultures. Preexercise values are represented by the white columns and postexercise values
by the black columns. Results are given as the mean ± SEM. ∗ indicates a p value of <.05 (two-sided t-test for dependent samples). PHA:
phytohemagglutinin.
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Aerobic exercise (min)

150

Postexercise CTXI levels correlated inversely with estradiol levels (Figure 8).

r = −0.3267
p = .0347
r2 = 0.1068

100

3.8. Exercise Parameters. Subjects trained an average of 2.5
hours per week (range 0.3–7.4 hours). The average duration of
each exercise session was 71 minutes (range 36–123 minutes),
and the average number of visits per week was 2 (range 1
to 5). During each training session, subjects divided their
time between aerobic (57%), resistance (weightlifting) (35%),
and flexibility (stretching) (8%) exercises. Aerobic exercises
included walking or running (32%), cycling (16%), aerobics
(3%), rowing (3%), climbing (2%), and skiing (1%).

50

0
−100

0

100

200

Osteoclastogenic cytokines (percent change)

Figure 3: Exercise modality and cytokine production. Osteoclastogenic cytokine levels fell in proportion to the time subjects spent in
each training session doing aerobic exercises (Pearson correlation
test with regression analysis). Data points for cytokines are the sum
of IL-1𝛼, TNF-𝛼, and IFN-𝛾 values.

(𝑝 = .0012) and showed no change in PHA− cultures. IL6 levels increased by 50% in PHA+ cultures and by 112% in
PHA− cultures (𝑝 < .0001) (Figure 4). In both PHA+ and
PHA− cultures, IL-6 production was linearly related to body
weight (Figure 5).
Collectively, antiosteoclastogenic cytokine production
increased by 50% in PHA+ cultures and by 89% in PHA−
cultures (𝑝 < .0001).
3.4. Growth and Differentiation Cytokines. Postexercise IL-2
levels increased by 116% in PHA+ cultures (𝑝 = .0470) and by
63% in PHA− cultures (𝑝 < .0001) (Figure 6). IL-12 levels fell
by 40% in PHA+ cultures (𝑝 > .05) and showed no change in
PHA− cultures.
3.5. Lymphocyte Phenotypes. Levels of lymphocytes expressing LFA-1, an integrin that augments endothelial cell adhesion, increased by 21% in response to exercise (𝑝 = .0033).
B1 (IL-10+ B repressor) cell counts and percentages increased
by 330% (𝑝 = .0580) and 190% (𝑝 = .0464), respectively,
and CD4/CD8 ratios fell by 5.6% (𝑝 = .0129). There were
no significant changes in the levels or percentages of other
lymphocyte phenotypes.
3.6. Mitogenic Responses. PHA-induced proliferative
responses of T cells fell from 9,142 ± 760 Δcpm to 3,155±
584 Δcpm following exercise (𝑝 < .0001). The reason for this
change is not known, although it may reflect the change in
CD4/CD8 ratios and an increased activity of suppressor cell
populations (e.g., M2 monocytes, B1 cells, and T repressor
cells).
3.7. Serum Factors. CTXI levels fell by 16% (𝑝 = .0128) and
osteocalcin levels increased by 9.8% (𝑝 > .05) in response
to the exercise program (Figure 7). There was no significant
change in serum levels of estradiol, testosterone, parathyroid
hormone, or insulin-like growth factor-1 following exercise.

3.9. Group and Within-Group Variations
3.9.1. Cytokines. PBMCs taken from men prior to exercise spontaneously produced more IFN-𝛾 and TNF-𝛼 than
mononuclear cells taken from women (𝑝 ≤ .04). Following
exercise, men spontaneously produced more IL1-𝛼 and TNF𝛼 than women (𝑝 ≤ .004).
In both men and women, exercise attenuated the production of TNF-𝛼 and IFN-𝛾 (𝑝 ≤ .0062) and enhanced the production of IL-6 and TGF-𝛽1 (𝑝 ≤ .0028) in PHA-stimulated
cultures. Postexercise levels of TGF-𝛽 also increased in PHA−
cultures in both groups (𝑝 ≤ .0049) (two-sided t-test for
dependent samples) (Figures 9 and 10).
3.9.2. Habits and Body Metrics. Four subjects (9.3%) changed
their diet to one that was lower in energy intake and animal
fat, and 2 of the 5 tobacco users discontinued smoking during
the study. There were no changes in medications or alcohol
consumption.
By completion of the study, 32% of the women and 27%
of the men had lost weight, and 4% of the women and the 11%
of men had gained weight; there was no significant change in
the mean weight of either group.
No group or within-group differences could be demonstrated as a result of weight change, menopause, use of
medications, alcohol consumption, or smoking (one-way
ANOVA).

4. Discussion
The primary effect of our exercise program was to change the
balance between PBMCs producing osteoclastogenic cytokines and those producing antiosteoclastogenic cytokines. It is
likely that similar changes occurred in hematopoietic cells
occupying the microenvironment of bone where they are
ideally situated to influence the ontogeny and functioning
of cells responsible for bone formation (osteoblasts), bone
resorption (osteoclasts), and the transduction of bone loading signals (osteocytes) (see Table 2). This conclusion is
supported by the finding that our exercise program caused
significant reductions in serum levels of CTXI, a reliable
marker of bone resorption, and modest rises in osteocalcin,
a reliable marker of bone formation [53]. Postexercise levels
of CTXI correlated inversely with estradiol levels, suggesting
that estradiol enhanced the antiresorptive effects of exercise,
a conclusion in keeping with the report of others that the
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∗
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0
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0

Figure 4: Effect of exercise on antiosteoclastogenic cytokine production. Exercise enhanced the production of IL-6, IL-10, and TGF-𝛽 in
PHA− cultures and IL-4, IL-6, and TGF-beta in PHA+ cultures. Preexercise values are represented by the white columns and postexercise
values by the black columns. Values for IL-4 and IL-10 are listed on the left y-axis, values for IL-6 and TGF-𝛽1 are listed on the right Y axis.
Results are given as the mean ± SEM. ∗ indicates a p value of <.05 (two-sided 𝑡-test for dependent samples). PHA: phytohemagglutinin.

PHA− cultures

400

r = 0.4129
p = .007
r2 = 0.1698

r = 0.3799
p = .0143
r2 = 0.1443
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Weight (lbs)
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300

PHA+ cultures
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0

0
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IL-6 (pg/mL)
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20000

40000
IL-6 (pg/mL)

60000

80000

Figure 5: Body weight and IL-6 levels. In both PHA− and PHA+ cultures, IL-6 values correlate linearly with body weight (Pearson correlation
test with regression analysis).

beneficial effect of exercise on bone density is blunted after
menopause [54].
Our study participants averaged two and one-half hours
of moderate intensity exercise per week: the same amount
of exercise recommended for adult men and women by the
World Health Organization for maintenance of health [55].
Participants divided their time between aerobic exercises
(57%), resistance exercises (35%), and flexibility exercises
(8%) and spent an average of 71 minutes in each training
session. Extended over a six-month period, this amount
of exercise was sufficient to reduce the spontaneous and
PHA-induced production of osteoclastogenic cytokines by 24

and 59%, respectively, and to increase the spontaneous and
PHA-induced production of antiosteoclastogenic cytokines
by 89% and 50%, respectively. In PHA-stimulated cultures,
osteoclastogenic cytokine production fell in proportion to the
time subjects spent in each session doing aerobic exercises.
Cross-sectional studies involving adult subjects and using
bone mineral density measurements have shown that exercises involving high impact (e.g., jumping) and high resistance (e.g., weightlifting) appear to be particularly effective
in improving bone mass and content, especially when the
intensity of the exercise is high and the speed of movement
is elevated. Loaded (weight-bearing) aerobic exercises such
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Figure 6: Effect of exercise on IL-2 production. Exercise increased
the production of IL-2 in both PHA− and PHA+ cultures. Preexercise
values are represented by the white columns and postexercise values
by the black columns. PHA− culture values are listed on the left
Y axis and PHA+ culture values on the right Y axis. Results are
given as the mean ± SEM. ∗ indicates a p value of <.05. PHA:
phytohemagglutinin.
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Figure 8: Estradiol and the antiresorptive effect of exercise. Postexercise CTXI levels correlate inversely with estradiol levels (Pearson
correlation test with regression analysis). The results suggest that
estradiol enhanced the antiresorptive effects of the exercise training
program. Note: the correlation improves with removal of the
apparent outlier (425 pg/mL estrogen): 𝑟 = −0.3376 and 𝑝 = .029.

10000

30

10
2000

0

0

Osteocalcin

CTXI

0

Figure 7: Scattergram showing the effects of the exercise training
program on serum levels of osteocalcin and CTXI. Osteocalcin
levels increased by 9.8 percent (𝑝 > .05) and CTXI levels fell by 16%
(𝑝 = .0128). Preexercise values are depicted by white circles and
postexercise values by black circles. Osteocalcin levels are shown on
the left Y axis and CTXI levels on the right Y axis. Error bars show
the mean ± (SEM) (2-sided t-test for dependent samples).

as walking or running also have the potential to improve
bone mass in adults and have the added benefit of improving
cardiovascular conditioning [56, 57].
Studies on the impact of different exercise modalities on
biomarkers of bone formation and resorption support the
importance of both resistance and aerobic training in maintaining bone health. Fujimura and associates found that high
intensity resistance training (weightlifting) done three times
weekly for four months by 17 young male subjects caused
a sustained increase in serum calcitonin levels, although
plasma procollagen Type I C-terminal levels, a marker of
bone resorption, did not change [58]. In a study involving
56 previously inactive young women, Lester and associates

found that 8 weeks of resistance or combined aerobicresistance training increased serum levels of osteocalcin but
had no significant effect on markers of bone resorption
[59]. In a study more closely resembling ours, Alghadir
and associates found that 12 weeks of moderate intensity
aerobic training done for 45 to 60 minutes three times
weekly by 65 healthy subjects (36 males, 29 females) aged 30–
60 increased serum osteocalcin levels and decreased serum
levels of deoxypyridinoline, a marker of bone resorption [60].
In our study, it is of interest that postexercise culture
levels of IL-6 were proportionate to weight, which is a
measure of one’s mass times the intensity of the gravity
field (9.8 m/sec2 on Earth). It is possible, therefore, that the
failure of exercise programs to attenuate bone loss in the
microgravity of space is related, at least in part, to suboptimal
production of this pleiotropic cytokine. IL-6 exerts contextdependent effects on bone metabolism [5, 30, 31]. Although
it can stimulate osteoclastogenesis and bone resorption by
upregulating RANKL expression in osteoblasts [32], its effects
on bone metabolism are predominantly osteogenic and
antiresorptive. IL-6 enhances bone formation by promoting
the differentiation of osteoblast precursors [33, 34] and by
protecting osteoblasts against apoptosis [5, 35]; it can inhibit
bone resorption directly by downregulating RANKL signaling pathways in osteoclasts [36] and indirectly by suppressing
the production of TNF-𝛼 and IL-1 and stimulating the
production of IL-4, IL-10, and IL-1 receptor antagonist by
immune cells [37, 38]. It is also an essential growth factor for
B cells, the primary source of OPG in bone marrow stroma
[39], and can induce IL-2 production in T cells [38, 40, 41].
IL-6 is produced in osteoblasts and osteocytes in response
to bone loading signals and, like TGF-𝛽, plays an important
role in bone remodeling [42]. Thus, studies similar to that
described in this report would be of particular interest if done
on persons exercising in the microgravity of space.
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Figure 9: Osteoclastogenic cytokines in women and men. Exercise attenuated the production of TNF-𝛼 and IFN-𝛾 in PHA+ cultures in both
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Note that men spontaneously produced more osteogenic cytokines than women both before and after exercise.
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This study would have benefitted from the inclusion of a
nonexercising age- and sex-matched control group. Phenotypic analysis of Th17 and T regulatory cells and an assay
for the mononuclear cell production of IL-17, a cytokine
with osteoclastogenic activity, would also have been beneficial. Cardiorespiratory fitness measurements (VO2max ) done
before and after the exercise program was completed would
have added potentially useful information.

cytokines. This beneficial effect may be enhanced by estradiol,
emphasizing the importance of this hormone as a regulator
of bone metabolism. The results provide a new insight as
to how physical exercise contributes to the maintenance of
bone health and suggest a possible molecular mechanism
to explain the difference in the antiresorptive effects of
exercise done on Earth as compared to exercise done in the
microgravity of space.

5. Conclusions
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